In her debut blog, Éimear Foley reviews a recent meta-analysis that identifies possible differences between people experiencing depression and healthy controls.
[read the full story...]Cerebrospinal fluid biomarkers for depression
No Responses »
Remote measurement technologies for depression in young people: scalable solution or overplayed potential? #ActiveIngredientsMH
In her debut blog, Annabel Walsh summarises her #ActiveIngredientsMH project which explored the use of remote measurement technologies for depression in children and young people.
[read the full story...]“Nobody knows the trouble I’ve seen”. Depression and bipolar disorder in people with intellectual disabilities
Kathryn Mitchell and Stephen Moore summarise a recent prospective cohort study in the British Journal of Psychiatry, which looks at the incidence of unipolar and bipolar depression, and mania in adults with intellectual disabilities.
[read the full story...]Antidepressants for depression: new BAP guidance
Helge Hasselmann summarises the recently published evidence-based guidance on antidepressants for depression published by the British Association for Psychopharmacology.
[read the full story...]Health effects of depression: keeping economists’ models on track
Health Economist Christopher Sampson reports on a recent systematic review and meta-analysis, which shows health-related quality of life utility values vary between studies and economic models should consider this.
[read the full story...]